To the editor

Spine

Volumn 34, Issue 16, 2009, Pages 1740-1741

  Colomina, Maria J ^a   Bagó, Joan ^a   Fuentes, Inmaculada ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

BLEEDING; BLOOD TRANSFUSION; BLOOD VOLUME; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HUMAN; INTRAOPERATIVE PERIOD; LETTER; PRIORITY JOURNAL; RISK REDUCTION; SPINE SURGERY; DOUBLE BLIND PROCEDURE; METHODOLOGY; NOTE; ORTHOPEDIC SURGERY; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL; SPINE; TREATMENT OUTCOME;

ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; DOUBLE-BLIND METHOD; HUMANS; ORTHOPEDIC PROCEDURES; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPINE; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 74049155524     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181a9ce1f     Document Type: Letter

References (4)

1. Elwatidy S, Jamjoom Z, Elgamal E, et al. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study. Spine 2008;33:2577-2580
2. Urban MK, Beckman J, Gordon M, et al. The efficacy of antifibrinolytics in the reduction of blood loss during complex adult reconstructive spine surgery. Spine 2001;26:1152-1156
3. Fergusson DA, Hebert PC, Mazer CD, et al; the BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med2008;358:2319-31.
4. Tzortzopoulou A, Cepeda MS, Schumann R, et al. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database Syst Rev 2008;3:CD006883.